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AbstrACt
Objective Process evaluations (PEs) alongside 
randomised controlled trials of complex interventions are 
valuable because they address questions of for whom, 
how and why interventions had an impact. We synthesised 
the methods used in PEs of primary care interventions, 
and their main findings on implementation barriers and 
facilitators.
Design Systematic review using the UK Medical Research 
Council guidance for PE as a guide.
Data sources Academic databases (MEDLINE, SCOPUS, 
PsycINFO, Cumulative Index to Nursing and Allied Health 
Literature, EMBASE and Global Health) were searched from 
1998 until June 2018.
Eligibility criteria We included PE alongside randomised 
controlled trials of primary care interventions which aimed 
to improve outcomes for patients with non-communicable 
diseases.
Data extraction and synthesis Two independent 
reviewers screened and conducted the data extraction 
and synthesis, with a third reviewer checking a sample for 
quality assurance.
results 69 studies were included. There was an overall 
lack of consistency in how PEs were conducted and 
reported. The main weakness is that only 30 studies 
were underpinned by a clear intervention theory often 
facilitated by the use of existing theoretical frameworks. 
The main strengths were robust sampling strategies, 
and the triangulation of qualitative and quantitative 
data to understand an intervention’s mechanisms. 
Findings were synthesised into three key themes: (1) a 
fundamental mismatch between what the intervention 
was designed to achieve and local needs; (2) the required 
roles and responsibilities of key actors were often not 
clearly understood; and (3) the health system context—
factors such as governance, financing structures and 
workforce—if unanticipated could adversely impact 
implementation.
Conclusion Greater consistency is needed in the 
reporting and the methods of PEs, in particular greater 
use of theoretical frameworks to inform intervention 
theory. More emphasis on formative research in designing 
interventions is needed to align the intervention with the 
needs of local stakeholders, and to minimise unanticipated 
consequences due to context-specific barriers.
PrOsPErO registration number CRD42016035572.
IntrODuCtIOn
An accessible, effective and affordable primary 
healthcare (PHC) system is needed to equi-
tably reduce the rising non-communicable 
disease (NCD) burden.1–3 Complex interven-
tions which comprise ‘multiple interacting 
components (although additional dimensions 
of complexity include the difficulty in their 
implementation and the number of organ-
isational levels they target)’ are often used 
to reduce this burden.4 These interventions 
often require individual and organisational 
behaviour change within dynamic health 
system contexts.5 6 Randomised controlled 
trials (RCTs) of complex primary care inter-
ventions have been conducted, but there is 
often ambiguity as to what was implemented 
on the ground.4 7 8 Process evaluations (PEs) 
are conducted alongside trials to examine if 
a complex intervention was implemented as 
intended, and to explore if, for whom, how 
and why the intervention had an impact.4 
A process evaluation is defined by the UK 
Medical Research Council (MRC) as a study 
to ‘understand the functioning of an interven-
tion, by examining implementation, mechanisms 
of impact, and contextual factors’.4 The MRC PE 
framework and guidance published in 2015 
is based on the synthesis of influential frame-
works and theories in public health research, 
strengths and limitations of this study
 ► This is a reflexive thematic synthesis and interpreta-
tion of the papers by a multidisciplinary team.
 ► A bespoke quality assessment tool based on the 
Medical Research Council guidance for process 
evaluations was used.
 ► Given variations in lexicon, our search strategy may 
not have exhaustively captured all process evalua-
tions of complex primary care interventions.
 ► Use of the framework and quality assessment tool 
to synthesise the findings has not been tested 
previously.
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and informed by the authors’ PEs.4 The key points are 
briefly summarised and elaborated on in box 1.
In the guidance, concepts of reach, fidelity and adop-
tion were highlighted as key to examining implementa-
tion quality. For example, assessing ‘fidelity’ would help 
determine whether the research was conducted as per 
protocol. The MRC guidance also highlighted the value of 
describing the intervention theory more explicitly, that is, 
providing the hypothesis relating to how the complex 
intervention could potentially interact with contextual 
factors to produce variation in outcomes.9 10 Ideally, the 
intervention theory would determine the process (quali-
tative and quantitative) data to be collected and analysed 
before the RCT outcomes are known. The PE findings 
could potentially help explain variation in RCT outcome, 
refine the intervention theory and inform future 
research priorities. Recognising the need to facilitate 
implementation of evidence into practice and policy, the 
MRC guidance also expands on the importance for PEs 
to be conducted across all stages of research, that is, feasi-
bility/piloting, evaluation of effectiveness and post-eval-
uation stages. While the guidance was well received, 
outstanding questions remain in this developing field. 
For example, what is the role of other theories and frame-
works for PEs? What methods can be used and how?11–13 
Synthesising the collective ‘experience’ described in 
published PEs may answer some of these questions.
This review has two primary objectives. First is to review 
the methods used in published PEs and their alignment 
with the MRC guidance, and second to identify the key 
implementation barriers and facilitators reported in 
these PEs. We used the three key points (as summarised 
in box 1) from the MRC guidance as a lens to evaluate the 
published literature, and employed it as a framework for 
synthesising our findings.
MEthODs
The systematic review protocol has been prespecified and 
published in detail as a separate protocol.14 A summary of 
the methods is presented here according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) guidelines (see online supplementary 
appendix 1 for the PRISMA checklist).15
Eligibility criteria for the rCts with the included PE
 ► Population: patients with NCDs (diabetes, depression, 
cardiovascular disease, chronic obstructive pulmo-
nary disease, chronic kidney disease, type 2 diabetes 
mellitus) and their primary care providers.5
 ► Intervention: complex interventions which comprise 
‘multiple interacting components although additional 
dimensions of complexity include the difficulty of their imple-
mentation and the number of organisational levels they 
target’ within PHC.4
 ► Comparator: the control condition may include treat-
ment as usual, active control or placebo control.
 ► Outcomes for this systematic review: (1) strengths 
and limitations of each PE using the MRC guidance 
as a reference point; and (2) identification of imple-
mentation barriers and facilitators for the complex 
interventions.
 ► Timing: published data from 1998 until June 2018.
 ► Design: PE of the included RCTs as defined by the 
MRC as ‘a study which aims to understand the functioning 
of an intervention, by examining implementation, mecha-
nisms of impact, and contextual factors’.4 Given that PEs 
are often not explicitly labelled as such,10 we included 
studies with comparable aims.
 ► Exclusion criteria: not a journal article, not a report 
based on empirical research, not reported in English, 
reviews and not human research.
 ► Search strategy and data extraction: databases 
reporting academic publications (MEDLINE, 
SCOPUS, PsycINFO, Cumulative Index to Nursing 
box 1 summary points of the Medical research Council 
guidance for process evaluations
1. Expanded on the functions of the process evaluation.
Implementation: ‘What is implemented and how?’
 ► Implementation process: What did the research team do?
 ► Reach: Did you recruit participants that your intervention was in-
tended to have an impact on?
 ► Fidelity: Did you do what you planned to do as per protocol?
 ► Adaptation: What changes were made in the delivery of the inter-
vention to the local context?
 ► Dose: Is the frequency of the intervention delivered as planned?
Mechanisms of impact: ‘How does the delivered intervention produce 
change?’
 ► Participants’ experiences of the intervention.
 ► Mediators.
 ► Unexpected consequences and pathways.
Context: ‘How does the context affect implementation and outcomes?’
 ► Contextual factors which shape the theory of the intervention.
 ► Contextual factors that could affect and be affected by implementa-
tion, mechanisms and outcomes.
 ► Causal mechanisms within the context that could potentiate the 
effects.
2. Provided a systematic approach to the design and conduct of process 
evaluations.
 ► Planning: relationships with stakeholders and degree of separation 
between evaluators and research team.
 ► Design and conduct: describe intervention and causal assumptions, 
identify the key process questions, and inform data collection.
 ► Analysis: use of reporting guidelines for methods; transparently re-
port whether process data are analysed and reported prior or after 
knowing outcomes.
 ► Reporting: intervention theory and how it informed data collection; 
protocol to link multiple outputs.
3. Described and expanded on the function of process evaluations across 
the different stages of development, evaluation and implementation.
 ► Development: feasibility and acceptability of implementation strate-
gies and optimising design and evaluation of intervention.
 ► Effectiveness: fidelity of intervention, mechanisms of action and 
contextual factors.
 ► Post-evaluation implementation: implementation of intervention into 
usual practice, long-term surveillance.
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and Allied Health Literature, EMBASE and Global 
Health) were searched. Standard systematic review 
methods were followed for searching, screening and 
extracting data from eligible studies.14 Our search 
strategy is included as online supplementary appendix 
2. Two reviewers (HL, AM) conducted most of the 
data extraction, with a third reviewer (MN) assisting 
in data extraction with some papers and as part of 
quality assurance, and checked on the data extraction 
for a 10% sample of the identified papers. Given that 
a key aim of this study was about PE methodology, 
we deviated from the published systematic review 
protocol, by including our interpretation in addition 
to the study’s strengths and limitations posited by the 
authors of those papers.
Data analysis and synthesis
Descriptive items (eg, number of positive RCTs) were 
tallied and synthesised into three tables: (1) Overall char-
acteristics: presenting the studies grouped into different 
diseases and ordered by year of publication (online 
supplementary appendix 3); (2) methods table: grouping 
studies by the stages of the PE (ie, feasibility/piloting, 
effectiveness, post-evaluation) (online supplementary 
appendix 4); and (3) quality assessment: findings based 
on a bespoke assessment tool which was designed based 
on some of the key recommendations from the MRC 
guidance and two other papers which had synthesised PE 
literature before (online supplementary appendix 5).
Extracted qualitative data were coded by HL, and 
grouped into categories of context, mechanisms and 
implementation. Inductive derivation of the key themes 
was done through constant comparison between the find-
ings from the papers within each category and examining 
the relationships between them. Online supplementary 
appendix 6 provides illustrative quotations. Using a modi-
fied MRC framework, we mapped our methodological 
and implementation findings to triangulate and synthe-
sise our findings.
Patient and public involvement
While patient and public perspectives were synthesised 
from published papers, no public and patients were 
directly involved in this study.
FInDIngs
Characteristics of included studies
We identified 69 studies. The PRISMA flow chart is 
presented in figure 1. In summary, 66 studies were 
conducted in high-income countries, 1 study in Zambia, 
1 in Malaysia and 1 in India. Cardiovascular disease, 
diabetes mellitus and depression were the conditions 
most often investigated, with only six studies on chronic 
obstructive pulmonary disease and one study on chronic 
kidney disease. Overall, the complex primary care inter-
ventions fit within the general categories of facilitating 
patient self-management (13 studies), organisational 
change to include collaborative care (15 studies), facili-
tating better case management using clinical information 
systems (eg, telehealth) (15 studies), and the use of deci-
sion support and guideline implementation (eg, referral 
systems) (22 studies). In addition, five studies explored 
the challenges when conducting trials in primary care, for 
example, the recruitment of patients.
Only 22 studies were labelled clearly as PEs, although 
this was more common in recent years. Twenty studies 
were conducted at the feasibility stage with 5 labelled 
as PEs, 43 studies at the effectiveness stage with 17 
labelled as PEs, and 6 studies at the post-evaluation 
stage with none labelled as PEs. (The methods used at 
these different stages are described in greater detail in 
the next section.) In 35 studies the degree of separation 
between the process and outcome evaluation researchers 
was explicit. The cost considerations for the system and 
stakeholders were mentioned in 10 papers (see table 1 
for more details). In figure 2, the context of the studies 
and an overview of the main methodological and imple-
mentation findings are diagrammatically presented in an 
adapted PE framework.
PEs’ strengths and limitations
Description of intervention theory: clear intervention description 
and clarification of causal assumptions
Thirty papers were assessed as having clear intervention 
descriptions and clarification of causal assumptions, and 
in 16 it was unclear because despite clear intervention 
descriptions the causal assumptions were not described 
explicitly. An example of a paper that explicitly describes 
intervention theory is Grant et al, who uses the Template 
for Intervention Description and Replication (TIDieR) 
checklist to clearly describe researchers’ assumptions of 
Figure 1 PRISMA figure. PRISMA, Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses; RCT, 
randomised controlled trial.
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Table 1 Summary of the characteristics of the included studies




20 studies on 
depression.
Interventions mostly around collaborative care 
through increasing expertise of different roles (eg, 
lay worker, nurse for proactive care, GP for PHC) 
(16 studies), times to implement practice guidelines 
(4 studies), and trialling specific interventions such 














17 studies on diabetes. The interventions included improving guideline-
based referral and treatment (7 studies), patient 
self-management, community support (7 studies) 
















25 studies on CVD. 10 studies were about improving the screening 
and management of CVD using best-practice 
guidelines (eg, educational materials to improve 
referral or decision analysis). 10 studies were about 
organisational change with models of care that 
incorporated new roles such as a nurse-led clinic, 
or the use of a lay worker for angina management, 
and technology (eg, telemonitoring, point of care 
testing). 5 studies explored trial implementation 
such as recruitment of patients and providers, and 















6 studies on COPD 
(2 including other 
chronic disease) and 1 
addressing CKD.
4 studies were about improving self-management 
of patients through educational materials, or use 
of monitoring, with support from health providers. 
2 studies were about stimulating physical activity 
through the use of technology. 1 study was about 













Overall synthesis of 69 
studies in total.
20 depression, 17 
diabetes, 25 CVD, 6 
COPD and 1 CKD.
Overall, the complex primary care interventions fit 
within the general categories of facilitating patient 
self-management (13 studies), organisational 
change to include collaborative care (16 studies), 
facilitating better case management using clinical 
information systems (eg, telehealth) (15 studies), 
and the use of decision support and guideline 
implementation (eg, referral systems) (22 studies). 
In addition, 5 studies were exploring the conduct 















In addition, 2 studies 
focused on First Nations 
peoples in Australia and 
in Canada. 3 studies 
were focused on the 








*Of note two were full evaluation reports (outcome, process and economic evaluations) in the UK journal of Health Technology Assessments 
in addressing the question of whether an innovation with limited evidence base in a pragmatic setting (eg, introducing cognitive–behavioural 
therapy in schools) should be scaled up. Eight papers included descriptions of how cost considerations such as financing incentives/
government subsidies impacted on intervention implementation.
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; GP, general practices; N, no; NA, 
not applicable; PHC, primary healthcare; RCT, randomised controlled trial; Y, yes.
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the intervention’s mechanism as compared with stake-
holders’ perspectives.16
Use of existing theories and frameworks
A strength of 22 studies was the use of existing theoretical 
frameworks to inform their intervention development 
and/or evaluation (see table 2). Theories and frameworks 
used are grouped according to Nilsen’s proposed catego-
ries.17 This is depicted in box 2, with illustrative examples 
from the identified studies. In essence, 11 studies used 
classic theory to inform the development of the interven-
tion theory. In eight studies determinant, implementation 
theories and evaluation frameworks were used to assist in 
the synthesis and analysis of qualitative data. The authors 
of two studies also used their findings and implementa-
tion theories to iteratively inform their implementation 
strategies. The evaluation frameworks were used by study 
authors to comprehensively evaluate and synthesise their 
PE data. The MRC framework for complex interventions 
was used to inform the approach to intervention develop-
ment in three studies.
The use of theoretical frameworks seems to enable 
an indepth investigation of stakeholders’ perspectives 
of the perceived mechanisms of the intervention, by in 
a sense providing a checklist of actions and behaviours 
to be examined.18–28 An illustrative example is the PE 
of a trial in improving primary care referrals of patients 
with diabetic retinopathy to specialists through the use 
of educational printed materials.28 A behavioural theory 
was used to inform the design and use of a questionnaire 
to explore the mechanism of the intervention. It was 
found that the primary care providers’ intention to refer 
patients was the same before and after the trial, and 
this may have explained their negative trial results. The 
authors highlighted that the use of existing behavioural 
theory enhanced the ‘generalisability and replicability’ of 
their methods.
Interaction with contextual factors
In 14 papers the interaction of the intervention and 
contextual factors was explicitly explored. As mentioned 
above, theoretical frameworks often facilitated a closer 
and systematic way to consider context. For example, 
the authors examined if there was ‘contextual integra-
tion’, that is, organisational changes necessary to integrate 
a collaborative model of care for depression into routine 
practice.29 Otherwise, contextual factors (eg, impact of 
the introduction of a new policy30) were reported retro-
spectively in some papers in a more ad hoc manner, for 
instance being reported as implementation facilitators 
and barriers, or discussed as possible influences on the 
outcomes.
Methods used
Assessing the studies based on our bespoke assessment 
tool, we found that most authors (64/69) clearly justified 
their choice of methods and stated the studies’ purpose, 
and most of the qualitative studies (42/50) were of 
a reasonable quality, with 24 of 50 studies covering all 
three domains of the Consolidated criteria for Reporting 
Figure 2 Medical Research Council process evaluation framework with tallies of studies, methods and synthesised 
findings. N/A, not applicable; RCT, randomised controlled trial.
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Qualitative research (COREQ) and 18 of 50 studies 
covering two domains. The methods could be catego-
rised as qualitative studies (eg, interviews, focus group 
discussions, documentary analysis), quantitative (eg, 
processes of care, baseline demographics, secondary 
outcomes), and studies which presented the synthesis 
of qualitative and quantitative data sources to indicate 
implementation, acceptability, fidelity and reach (see 
Table 2 Summary of the methodology used and quality assessment of the studies
Stage of process 
evaluation Methodology and methods Analysis Quality criteria
Feasibility/
Piloting, 20 studies.
9 studies used theories or frameworks. 18 
used interviews. 3 used focus group 
discussions, 4 used questionnaires or 
surveys, 2 studies used routine monitoring 
data, field notes, minutes of meetings and 
observations.
Thematic analysis, constant 
comparative approach most 
commonly used, with some using 
framework analysis.
Planning:
Team description: 11 Y, 6 N, 3 NA.
Design and conduct:
Purpose: 20 Y.
Intervention description and causal 
assumptions clarified:
5 Y, 6 unclear, 9 NA, 0 N.
Justify choice of timing and methods: 
19 Y, 1 N.












12 studies used existing theories and 
frameworks (6 classic theories,
3 evaluation frameworks, 3 implementation 
theories).
2000–2004: 3 studies documented specific 
processes of care as part of the process 
evaluation, which were reported as part 
of the main trial. 4 studies investigated 
acceptability of an intervention using 
surveys/questionnaires.
2005 onwards: 12 studies used interviews 
alone to explore implementation and 
acceptability; 20 studies used interviews 
triangulated with other sources of data 
(eg, chart audit). 2 studies used routine 
administrative data to indicate fidelity. 3 
studies used questionnaires or surveys.
Descriptive statistics were 
used for the quantitative 
data, and thematic, constant 
comparison and framework 
analysis for the qualitative data.
The studies that used mixed 
methods used the quantitative 
data to indicate level of 
implementation, reach and the 
dose. This was used to triangulate 
the qualitative findings on 
implementation and intervention 
acceptability. The studies which 
used evaluation frameworks (eg, 
RE-AIM) and implementation 
theories (eg, NPT) used them for 
the analysis and presentation.
Planning:
Team description: 21 Y, 21 N, 1 NA.
Design and conduct:
Purpose: 43.
Intervention description and causal 
assumptions clarified: 25 Y, 8 unclear, 
5 NA, 5 N.
Justify choice of timing and 
methods: 40 Y, 1 N, 2 NA.
Report whether the process data 
are analysed blind to trial outcomes/
or post-hoc: 29 Y, 7 N, 7 NA.






Clearly labelled as process 
evaluations: 17 (of note: 2 before 




1 study used existing theory. 2 studies used 
interviews, 2 used documentary analysis, 
and 1 used the administrative data and 
registry data.
Descriptive statistics, subgroup 
analysis and thematic analysis.
Planning:
Team description: 3 Y, 2 N, 1 NA.
Design and conduct:
Purpose: 6
Intervention description and causal 
assumptions clarified: 0 Y, 2 unclear, 
2 NA, 2 N.
Justify choice of timing and methods: 
5 Y, 1 N.








COREQ, Consolidated criteria for Reporting Qualitative research; N, no; NA, not applicable; NPT, normalisation process theory; RE-
AIM, reach, efficacy/effectiveness, adoption, implementation and maintenance framework; Y, yes.
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table 2 and online supplementary appendix 4 for more 
details).
A strength of some studies was the triangulation of 
quantitative indicators with the qualitative findings of the 
acceptability and implementation of the intervention to 
determine intervention fidelity (ie, whether the interven-
tion was delivered per protocol) (see online supplemen-
tary appendix 3 for more details).31 32 The data sources 
indicating intervention fidelity included routine admin-
istrative data, trial/study management logs21 and trial 
secondary outcomes.33–35 Innovative indicators of e-health 
interventions included recording process measures such 
as time logged on by participants.36 Another method to 
determine intervention fidelity across multiple sites was 
having independent expert assessors reviewing interven-
tion delivery using standardised forms. Three studies 
investigated ‘for whom’ an intervention had an impact 
on with the use of logistical regression of baseline demo-
graphics to identify relationships of participants’ charac-
teristics with the primary or secondary outcomes.37
Sampling limitations in the qualitative studies 
were described as potentially introducing bias in the 
findings about intervention acceptability/mecha-
nisms.18 19 23–25 28 38–42 For example, authors highlighted 
that respondents who having agreed to be inter-
viewed may have a more favourable opinion of the 
box 2 Illustrative examples of the use of theories and 
frameworks
Classic theories.
 ► Theory of planned behaviour. ‘Using the theory of planned behaviour 
(TPB), we hypothesised that changes in thiazide prescribing would 
be reflected in changes in intention, consistent with changes in 
attitude and subjective norm, with no change to their perceived 
behavioural control (PBC), and tested this alongside the RCT…A 
strength of this study is its use of a well-tested theory of behaviour 
operationalized according to best recommended practice to investi-
gate the underlying mechanisms of an implementation intervention’ 
(Presseau). This theory informed their process evaluation to explore 
if their intervention of printed educational materials increased prac-
titioners’ intention to prescribe according to recommendations in 
the guidelines.
 ► Self-determination theory. ‘self-determination theory which propos-
es that real shifts in behaviour arise through heightened autonomy 
or personal ownership of behavioural success’ (Chalder). This theory 
informed their theoretical model underpinning their intervention to 
improve physical activity for the management of depression.
 ► Grounded theory. ‘This qualitative study was conducted with the 
objective of better understanding the PP (Prevention practitioner) 
intervention in the BETTER Trial described above, including the de-
velopment of the PP (prevention practitioner) role, perceived barri-
ers, facilitators, benefits and disadvantages, and of exploring the 
feasibility and sustainability of this approach for CDPS (Chronic dis-
ease prevention and screening)’ (Manca). This study used grounded 
theory to better understand their intervention as implemented and 
to retrospectively describe their intervention theory.
 ► Diffusions of innovation. ‘Key principles, which derive from diffusion 
of innovations theory, include working initially with practices and 
clinicians that not only have an interest in the innovation and view 
it as compatible with their needs, values, and resources, but also 
have the ability to try it with minimal investment and observe its im-
pact’ (Dietrich). The theory was used to inform their practice change 
strategy for the sustainability of a chronic care model for depression 
proven effective in an RCT.
Determinant frameworks.
 ► PARIHS as an implementation model.  ‘We used the Promoting 
Action on Research in Health Services (PARIHS) framework as an 
‘Implementation model’ to assist clinical partners in adopting the 
health-coaching intervention. The PARIHS framework posits three 
interrelated elements that influence successful implementation of 
evidence-based practices: the (i) perceived strength of the ‘evi-
dence’, (ii) ‘context’ of the environment and (iii) ‘facilitation’ support 
created for implementation of the intervention…Using a codebook 
developed a priori from sub elements of the PARIHS framework’ 
(Naik). This study used PARIHS to inform their participatory ap-
proach between research team and primary healthcare teams, and 
also used it in evaluation of the qualitative data in assessing the 
building of the partnership to test and implement a health-coaching 
intervention.
Implementation theories.
 ► Normalisation process theory. ‘as part of mixed-methods process 
evaluation, semi-structured interviews were conducted by phone 
with 27 providers participating in the study. Interviews were au-
dio-taped and transcribed. Thematic content analysis was used to 
identify themes. Themes were categorized according to the four do-
mains of Normalization Process Theory (NPT)’ (Vest). The authors 
Continued
box 2 Continued
discuss how the findings are informing their ongoing implementa-
tion strategies, for example, clinical mentors for the general prac-
titioners who described a discomfort in their lack of expertise in 
screening and managing early chronic kidney disease (other papers 
include Burridge, Coupe, Gask, Hanley, Vest).
Evaluation frameworks.
 ► Medical Research Council’s (MRC)  framework for complex inter-
ventions. ‘The MRC framework provided a useful structure through 
which to examine our theoretical hypothesis and analyse the feasi-
bility evidence’ (Sturt). ‘Guided self-help intervention was developed 
following a modelling phase which involved a systematic review, 
meta synthesis and a consensus process…’ (Lovell). The authors 
used the MRC framework for intervention development. Similarly 
Byrne et al also used the MRC framework for intervention develop-
ment of literature review, focus group discussion and modelling and 
then interviews to refine the intervention.
 ► RE-AIM. ‘The process evaluation followed the RE-AIM (Reach, 
Efficacy/effectiveness, Adoption, Implementation and Maintenance) 
framework. Data were collected on attendance and attrition for 
classroom-based CBT and attention control PSHE (Personal, Social 
and Health Education) by programme facilitators. An independent 
observer attended 5% of classroom based CBT sessions to assess 
treatment fidelity. Feedback was gathered from teachers, young 
people and facilitators using questionnaires and qualitative inter-
views’ (Stallard) (other papers include Stallard, Wozniak, Lakeverld).
 ► Realist evaluation. ‘All data assigned to codes relating to the polyp-
ill strategy in CVD management were analysed…and the Realist 
framework of context–mechanism–outcomes utilized to develop the 
themes’ (Liu). The framework was used to guide the analysis of the 
qualitative data.
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intervention.18 38 43–45 Maximum variation sampling (types 
of participants, sociodemographics, by ‘negative’ baseline 
of outcome characteristics’), comparing the characteris-
tics of participants who did not partake in the interviews/
surveys with the participants who did, and triangulation 
with other data sources may increase the robustness of 
such findings.19 20 22 28 38 39 46
PE findings under mechanisms, implementation and context
Does the intervention fit local needs?
Stakeholders were generally motivated to adopt/imple-
ment the complex intervention if it addressed the contex-
tual gap in care, that is, intervention fit. For example, a 
nurse-led secondary prevention clinic was implemented 
effectively when the health providers perceived it as 
improving teamwork, care continuity and providing a 
‘safety net’ for the patients. In contrast, at other sites, this 
intervention was poorly implemented by the healthcare 
providers who viewed it as duplicating the existing model 
of care.47 As another example, general practitioners 
reported that training them to manage acute and discrete 
episodes of depression did not improve their manage-
ment of depression. This was because this training did 
not upskill them for the chronic and relapsing nature of 
depression associated with personality and social prob-
lems increasingly seen in primary care.41 48 Similarly, 
patients’ health literacy about their chronic disease (eg, 
effectiveness of lifestyle modification for diabetes) was 
crucial as it affected engagement with the PHC services 
and their uptake of the intervention.22 25 49–51
Do key actors believe in and adopt their ‘assigned’ roles and 
responsibilities?
The extent to which key actors believed in and adopted 
their ‘assigned’ roles and responsibilities as part of imple-
menting the complex intervention was a key theme under 
the heading ‘Implementation’.21 26 27 42 43 48 52 For example, 
in a study which used telemonitoring to improve manage-
ment of patients with chronic obstructive pulmonary 
disease in the community, there were differing views of 
the role of the patient. Some health providers described 
concerns that telemonitoring would reinforce the ‘sick 
role’ of the patient, and an over-reliance on technology 
and practitioner support. Therefore, they were less 
willing to implement this model of care. On the other 
hand, some patients described that telemonitoring was 
empowering as it provided knowledge and increased 
access to health practitioners who could provide reassur-
ance in the management of the disease, and were thereby 
keen to continue this model of care.22
Facilitators to improve key actors’ uptake of the inter-
ventions included the provision of intense training over 
a transition period prior to the start of the trial, signifi-
cant research support, and ongoing communication with 
the researchers to help identify key actors’ concerns and 
tailor implementation strategies to address them. For 
example, ensuring adequate communication between 
nurse practitioners and general practitioners was essential 
in task-shifting models of care. This facilitated greater 
trust between nurse practitioners and doctors, which was 
needed to effectively deliver collaborative services.42 52 
Such strategies were especially relevant for collaborative 
care interventions where new tasks were introduced 
within established hierarchical systems and interaction 
between different stakeholders was necessary for effective 
implementation.
Is the context of the intervention conducive?
Health system structures such as governance, health 
financing structures and workforce were often 
mentioned as impacting on intervention implementa-
tion. Governance structures were pivotal to the successful 
adoption of the intervention.23 33 For example, an inter-
vention to enhance referrals to mental health services 
was implemented well at a site when the intervention was 
perceived as ‘service delivery’ and directly supported by 
the mental health trust. In comparison, uptake of the 
intervention was limited when the intervention was not 
viewed as ‘service delivery’ and was considered ‘primary 
research’.33 Similarly, cultivating a strong partnership 
between researchers and clinicians through the forma-
tion of clinical advisory teams facilitated intervention 
implementation in bureaucratic and geographically 
complex environments.23 Limited workforce, equip-
ment shortages and inadequate funding structures were 
reported by several authors as barriers to the interven-
tion adoption. For example, health providers stated that 
the lack of government reimbursement for allied health 
services reduced the acceptability of the telehealth model 
of care for ongoing monitoring of diabetes at home.39 
General practitioners reported that time constraints 
in their busy practices prevented them from using the 
skills they learnt through an educational intervention 
to better manage depression.41 Likewise, macro-level 
context, such as medication being out of stock in rural 
Zambia, was a barrier to better outcomes, in spite of the 
provision of an evidence-based intervention to improve 
clinical assessment and management.32
Importantly, an iterative collaborative approach was 
described as a facilitator of intervention fit.18 36 45 50 51 53 54 
For example, study authors described how early stake-
holder involvement identified the key characteristics of 
the lay worker needed (ie, female, with visibility in the 
community) for their intervention to improve mental 
healthcare in India. This preparatory phase in the devel-
opment of their model of care led to a definitive RCT 
with positive outcomes. In their PE of the RCT, they 
found that the provision of a lay worker was not rele-
vant for the primary care practitioners in private prac-
tice who had established therapeutic relationships with 
their patients, but more so for the health providers in the 
public system who were time-poor. These findings would 
then inform future scale-up of the intervention within the 
right context (ie, public health system) for the interven-
tion.53 55
9Liu H, et al. BMJ Open 2019;9:e025127. doi:10.1136/bmjopen-2018-025127
Open access
DIsCussIOn
statement of principal findings
To our knowledge this is the first systematic appraisal 
using MRC guidance on PEs of primary care interven-
tions. Of 69 studies, 66 were conducted in high-income 
countries, while cardiovascular disease, diabetes and 
depression were the most frequently studied conditions. 
There was an overall lack of consistency in the way PEs 
were conducted and reported. Indeed there was a lack 
of consistency in nomenclature, with only 47 of the 69 
studies identifying as ‘process evaluations’, although 
their purpose was essentially as such. Few studies (n=30) 
were underpinned by an intervention theory, descrip-
tion of hypothesised intervention mechanisms of action 
within local contextual factors. Most studies used robust 
sampling strategies and frequently triangulated qual-
itative and quantitative data to better understand the 
mechanisms of implementation. The MRC PE guidance 
with its focus on the interaction/configuration between 
context, implementation and mechanisms of interven-
tion provided a useful framework for the synthesis of the 
findings. Mapping our findings on the framework also 
gives our findings and assessment tools greater validity. 
The findings of these studies can be synthesised into a 
number of key messages: (1) that often there was a funda-
mental mismatch between what the intervention was 
designed to achieve and local needs; (2) that the roles 
and responsibilities of key actors required to implement 
the intervention were often not clearly understood; and 
(3) that health system context—factors such as gover-
nance, financing structures and workforce—were often 
critical to implementation, and as a consequence there 
were a number of studies where the unanticipated influ-
ence of these adversely impacted on implementation.
Comparison with other literature and implications
A key finding is identifying the breadth of literature which 
fits the MRC definition of PE. This highlights the growing 
scope in this field to potentially address the evidence to 
practice gap through greater understanding of the inter-
actions between intervention mechanisms, context and 
implementation.12 56 57 However, greater consistency is 
needed in the reporting of PEs—as this would facilitate 
evidence synthesis, prevent research duplication and 
enhance transferability of interventions to other settings.58 
We note that the consistency in reporting seems to have 
increased since the publication of the MRC guidance.
An important finding is that theoretical frameworks 
helped guide a more indepth development of interven-
tion theory, design and implementation.12 59 The MRC 
PE guidance suggests that PE can help to explain the 
outcomes variations, and by doing so help refine the 
intervention theory.17 We note that given the growing 
focus on self-management for chronic diseases, the theo-
ries around behavioural change (eg, empowerment) were 
most commonly used. Second, the focus on organisational 
change and the adoption of guidelines in NCDs meant 
that implementation theories such as the normalisation 
process theory (NPT) were particularly relevant. There-
fore, there should be more consistent use of theoretical 
frameworks, recognising that different frameworks will 
be applicable to different settings. In addition, the use 
of checklists such as the TIDieR or the Standards for 
Reporting Implementation Studies (StaRI) will ensure 
consistency in the reporting of intervention theory and 
implementation, thus reducing research waste.56 60 61 We 
also note that there were only six ‘post–evaluation’ studies 
identified. This is not surprising as implementation and 
translational research is a more recent phenomena, and 
there may have been less funding for such work and 
greater difficulties in publishing such findings, a point 
likewise raised in the MRC guidance report in 2015. We 
anticipate, however, that more implementation research 
will be published as this emerging field matures.
We found that the intervention interaction with dynamic 
contextual factors was often inconsistently reported or 
reported retrospectively in an ad hoc manner. This gap 
has been similarly reported in the literature.62 These 
findings emphasise MRC PE guidance’s value in explicitly 
appraising context through examining factors ‘that shape 
theories of how the intervention works’, and affect imple-
mentation, and act to ‘sustain the status quo, or poten-
tiate effects’.4 However, this guidance is relatively broad 
and non-specific, and the question remains as to what 
should be explored a priori and how best to report such 
findings. For example, the Context and Implementation 
of Complex Interventions framework highlights seven 
domains of context (‘geographical, epidemiological, socio-cul-
tural, socio-economic, ethical, legal and political context’) that 
could be examined.56 Similarly, the StaRI checklist has 
context as an item in the methods (ie, ‘consider social, 
economic, policy, healthcare, organisational barriers and facilita-
tors that might influence implementation elsewhere’) and in the 
results (‘contextual changes (if any) which may have affected 
outcomes’).60 These domains are comprehensive, and as a 
consequence if a study is to examine only a subset of these 
factors, it is better that this is prespecified in full acknowl-
edgement of the evaluation as a whole. This should be 
consistently reported and linked through a full report 
or reference to a protocol.4 As a baseline, a standardised 
PHC template informed by the questions ‘Does the inter-
vention fit local needs? Do the key actors believe in and adopt 
their ‘assigned’ roles and responsibilities? Is the health system 
context (looking specifically at health workforce, governance, 
health financing structures and availability of medications) 
conducive?’ and relevant implementation theories (eg, 
NPT) could be presented for testing in a systematic way. 
This could be done by PHC researchers engaging with 
stakeholders at various time points, and iteratively added 
to.63–65 Such an approach could potentially facilitate a 
greater shared understanding between stakeholders and 
greater consistency in the reporting of context.62 64 66–68
Most of these studies were conducted in high-income 
countries with established PHC systems and universal 
health coverage (eg, National Health Service in the 
UK). Therefore, some primary care interventions (eg, 
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improving referrals in collaborative care) may be of 
limited relevance to low-income and middle-income 
countries (LMIC) PHC systems given the different context 
especially with regard to health system structures.69 70 This 
reinforces the need for more formative research with 
local stakeholders when developing evidence-based inter-
ventions so as to address local needs, and minimise the 
unanticipated consequences of health system factors.71 72
strengths and limitations of this study
We were unable to conduct a subgroup analysis of imple-
mentation findings by country context (ie, of high-in-
come countries as compared with LMIC) as we identified 
studies conducted mainly in high-income countries. 
Some studies conducted in LMIC initially identified in 
the search were excluded because they did not meet 
our criteria (eg, not RCTs, not on NCDs), and as such 
a review with different inclusion criteria may be better 
suited for this secondary objective. A second limitation 
is that despite our extended search terms to include 
components of chronic care model, and similar terms 
as PEs, we may not have exhaustively captured all PEs of 
complex primary care interventions. We note, however, 
that we reached thematic saturation in our analysis across 
the spectrum of studies, which provides greater validity 
to our findings. Another limitation is that we appraised 
the studies using a tool which we developed based on the 
MRC guidance,4 which has not been tested elsewhere. 
This was challenging given the heterogeneous studies that 
were included. For example, we only assessed qualitative 
methods with COREQ, and did not appraise the quality 
of statistical methods such as modelling. A strength of 
this review is having a multidisciplinary team of authors 
with vast experience in clinical trials and PEs to enable 
a reflexive thematic synthesis and interpretation of the 
papers.73
COnClusIOn
Greater consistency is needed in the reporting of, and 
the methods used in, PEs. In particular there should be 
more consistent use of theoretical frameworks to inform 
intervention theory, and the triangulation of qualita-
tive and quantitative data. Greater emphasis on forma-
tive research in designing primary care interventions is 
needed so that they are clearly aligned with the needs of 
local stakeholders, that the roles and responsibilities of 
key actors are better understood, and that unanticipated 
consequences arising from context-specific barriers to 
implementation are minimised. We hope this review 
will inform future PEs and facilitate the sustainability of 
evidence-based interventions.
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